What Observe Medical does

Observe Medical ASA is a Nordic medtech company listed on Euronext Expand Oslo (ticker OBSRV), headquartered in Oslo with R&D and distribution operations through its wholly-owned Swedish subsidiary Observe Medical AB in Mölndal (Gothenburg). The company develops, manufactures, and markets proprietary medical devices for hospital urine monitoring and intra-abdominal pressure measurement, targeting ICUs, critical care, anesthesiology, and surgical settings across 46 countries.

The product portfolio is built around two technology platforms. The UnoMeter family (UnoMeter 500, UnoMeter Safeti Plus, UnoMeter Abdo-Pressure, and the newly launched UnoMeter Safeti Max) provides manual and closed-system hourly diuresis monitoring, unified by the patented KombiKon™ needle-free sampling system that reduces catheter-associated urinary tract infections (CAUTIs) by minimizing manual handling. The Sippi digital automated urine meter adds non-contact capacitive sensor measurement, SippCoat™ silicone oil biofilm-control technology, and Bluetooth connectivity to hospital Patient Data Management Systems for automatic data integration alongside other vital signs. All products target the global urological drainage market valued at approximately NOK 1.6-1.8 billion, with the addressable market expanding to NOK 2.6 billion.

The company operates a B2B distribution-led go-to-market model with exclusive local distribution partners in key markets (Skamex in Poland, SIM ITALIA in Italy, a partner in India signed March 2026) supplemented by direct Nordic operations. Revenue is generated from hardware sales of the UnoMeter portfolio and Sippi systems (base units plus disposable components). FY2025 revenue from the UnoMeter portfolio was NOK 18.8 million, with 64% portfolio growth and 80% YoY LTM growth reported in March 2026. Recent corporate actions include the wind-down of Biim Ultrasound AS (acquired 2022 for ~EUR 18.5M), a NOK 58.5M recapitalization in 2025, and a NOK 15M Innovation Norway loan to fund Sippi commercialization.

Name

Observe Medical

Legal name

Observe Medical ASA

Website

https://observemedical.com

Company type

Public

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Observe Medical ASA is a Nordic medtech company developing and selling proprietary urine monitoring devices (UnoMeter portfolio and Sippi digital system) for hospital ICUs, critical care, and anesthesiology markets across 46 countries via a B2B distribution network.

Ownership category

akta.pro rank

Product category

Medical Devices - Urine Measurement and Monitoring

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status) (HLAHAKAJ)

akta.pro secondary industries

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)

Keywords

• Urine measurement devices
• Urological drainage products
• Digital urine monitoring
• Intra-abdominal pressure monitoring
• ICU medtech equipment

Headquarters

HQ city

Gothenburg

HQ country

Sweden

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Marketing or Sales

Revenue model

1. Product Sales - UnoMeter Portfolio: Revenue generated from sales of the UnoMeter™ product portfolio including UnoMeter 500, UnoMeter Safeti Plus, and UnoMeter Abdo-Pressure. Products are sold through distribution networks across 46 countries. Full year 2025 revenue reached NOK 18.8 million with 64% growth from the UnoMeter portfolio.
2. Product Sales - Sippi Digital Urine Meter: Revenue from the Sippi digital and automated urine meter system, which includes a base unit with 3-year expected lifespan and disposable units recommended for up to 7 days usage. Launched commercially with expanded product offering planned.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

Observe Medical develops, manufactures, and sells proprietary medtech devices for hospital urine measurement and intra-abdominal pressure monitoring. The product portfolio includes the UnoMeter family (UnoMeter 500, UnoMeter Safeti Plus, UnoMeter Abdo-Pressure, UnoMeter Safeti Max) using the patented KombiKon needle-free sampling system, and the Sippi digital automated urine meter with non-contact capacitive sensors, SippCoat biofilm-control silicone oil technology, and Bluetooth integration into hospital patient data management systems.

Product overview

Observe Medical offers a portfolio of proprietary medtech products focused on urine monitoring and measurement. The portfolio includes the UnoMeter family (UnoMeter 500, UnoMeter Safeti Plus, UnoMeter Abdo-Pressure, and UnoMeter Safeti Max) for manual and automated urine output measurement and intra-abdominal pressure monitoring, all featuring the patented KombiKon sampling system. The Sippi digital urine meter provides automated measurement with Bluetooth connectivity for hospital data integration and biofilm control. All devices are designed for use in hospitals, ICUs, and anesthesiology settings.

Differentiator

Problem solved

Functional benefit

Brands

• UnoMeter: Manual urine output measurement product portfolio including UnoMeter 500, UnoMeter Safeti Plus, and UnoMeter Abdo-Pressure for intra-abdominal pressure monitoring. Features patented KombiKon sampling system.
• Sippi

Products and services

• Sippi A digital and automated urine meter system with biofilm control and wireless Bluetooth connectivity to hospital patient data management systems. Uses non-contact capacitive sensors for continuous urine output measurement, incorporating hourly diuresis tracking, data storage, and automatic emptying capabilities to minimize catheter-associated urinary tract infections (CAUTIs). Designed for ICUs, critical care units, and anesthesia settings.
• UnoMeter 500 Hourly diuresis monitoring system providing a 100% closed system with clinically-documented effectiveness. Combines accuracy and efficiency with the patented KombiKon sampling system for urine measurement procedures in hospital and critical care settings.
• UnoMeter Safeti Plus Hourly diuresis monitoring system focused on safety for healthcare professionals and patients. Combines accuracy and efficiency with maximum safety against cross-infection in urine output measurement procedures using the patented KombiKon sample collection system.
• UnoMeter Abdo-Pressure Intra-abdominal pressure (IAP) monitoring system for indirect monitoring of risk to abdominal organs and early detection of life-threatening ischemic conditions. The only device with a KombiKon sample collection system offering highest safety and accuracy in IAP measurement procedures.
• UnoMeter Safeti Max

Quantifiable outcome

• Minimizes catheter-associated urinary tract infections (CAUTIs) - the #1 hospital acquired complication for patients
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature4 records

Partnerships

One partnership is on record.

• India Distribution PartnercoreChannel Partner/ Reseller/ Distributor · 1 March 2026Exclusive distribution agreement with a local partner in India to distribute the UnoMeter™ product, replacing a previously announced letter of intent. The partner brings established sales networks and deep market knowledge within the Indian healthcare sector. CEO Jørgen Mann stated this milestone positions the company to scale commercial efforts and capture opportunities in India's high-growth healthcare market projected to reach USD 50 billion by 2030.

Scale indicators8 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Coloplast: Global leader in ostomy, continence, and urology care. Coloplast directly competes in urine collection and urological products for hospital and home use, with overlapping customers (ICUs, surgical wards) and similar clinical value proposition in infection prevention.
• ConvaTec: Major player in continence care, advanced wound care, and ostomy. ConvaTec competes directly in hospital urine management and continence devices, serving similar clinical buyers and channel partners as Observe Medical.
• Hollister Incorporated: Privately held medtech company specializing in ostomy, continence, and critical care products. Hollister offers urological drainage and urine measurement systems directly comparable to Observe Medical's UnoMeter portfolio.
• Teleflex: Diversified medtech company with a urology portfolio including urine meters and drainage devices. Teleflex competes in the same hospital ICU and surgical use cases where Observe Medical sells its UnoMeter and Sippi products.
• Potrero Medical (Verathon Accuryn): Developer of the Accuryn smart urinary catheter system for automated, digital urine output monitoring in ICUs. Most direct head-to-head competitor to Observe Medical's Sippi on digital urine measurement for critical care.
• Serres: Finnish-headquartered manufacturer of suction bags, fluid collection, and waste management systems for hospitals. Serres competes in adjacent fluid-management categories used by the same ICU and surgical customers.

Broad incumbents

• Becton Dickinson (BD): Global medtech incumbent offering urological drainage and urine measurement products as part of a much broader hospital portfolio. BD is not niche-specialized in urine monitoring but competes for the same hospital contracts.
• Cardinal Health: Large healthcare distributor and medtech manufacturer with a urological supplies portfolio. Cardinal Health serves as both competitor and potential distribution channel for Observe Medical's products.
• Medline Industries: Largest privately held manufacturer and distributor of medical supplies, including urological drainage and urine measurement products. Medline competes broadly for the same hospital purchasing budgets.

Emerging players

• ICU Medical: Manufacturer of IV therapy and critical care fluid management devices. ICU Medical is an emerging adjacent player in hospital fluid/infusion monitoring that overlaps with Sippi's ICU data integration use case.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/observe-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds12 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Observe Medical